Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. (Q48909236)
Jump to navigation
Jump to search
scientific article published in June 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. |
scientific article published in June 2005 |
Statements
Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma (English)
Senija Behrem
Kamelija Zarkovic
Neven Eskinja